May 6, 2025 | 11:00am – 12:00pm EDT
Explore the important links between site selection, feasibility, recruitment, and retention in clinical trials, and discover how to effectively integrate these interdependent tasks.
The survey is closed — thank you for participating!
Avoca, a WCG company, takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our survey aims to understand opinions and experiences as it relates to the final ICH E6(R3) guidance.
January 29, 2025 | 11:00am – 12:00pm EST
Join our webinar to understand the impact of these regulatory guidance changes to support successful adoption and get ahead of the curve.
January 28, 2025 | 11:00am – 12:00pm EST
ICH E6 (R3) final is here – let’s dive in! AQC members are invited to an informative session on key updates from E6 R2, R3 draft, and R3 final.
This year, Avoca's research focuses on potential changes in regulatory guidance under ICH E6 (R3) to gain understanding of current awareness and perceived impacts among clinical trial stakeholders to navigate the path forward.
Access The 2024 Avoca State of the Industry Report:
Anticipating ICH E6 (R3): Awareness, Impact & Preparedness
Join us as we discuss approaches to adopt innovative feasibility and site start-up solutions.
Read MoreNovember 5, 2024 | 11:00am – 12:00pm EST